Froome's salbutamol case led to spat between the UCI and WADA

cyclingtips.com
3 min read
standard
The UCI and WADA presidents had tense e-mail exchanges over the case.
Froome's salbutamol case led to spat between the UCI and WADA

Chris Froome (GBR/SKY) ©kramon

A report published by BBC Sport on Tuesday shed light on a spat between the UCI and WADA that arose in the aftermath of Chris Froome's salbutamol case.

Emails between UCI President David Lappartient and then-WADA president Craig Reedie show tensions between the organizations caused by the handling of that case.

Remind me, what happened in the Froome case?

Froome exceeded the allowable amount of salbutamol in a test during the 2017 Vuelta a España, which he won.

He denied wrongdoing and contended that a rider could exceed the allowable limit for the drug in testing without having taken more than the allowed amount. After a lengthy investigation, he was ultimately cleared. At the time, the UCI said that it made the decision that Froome's salbutamol result did "not constitute an adverse analytical finding" after "having received WADA's position."

What was said?

"The UCI was the results management authority with exclusive jurisdiction over the case and all relevant…
Read full article